Squadron Capital Management’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.74M Buy
+150,000
New +$3.9M 0.94% 31

Other funds holding TNGX

Squadron Capital Management's TNGX Position: Q3 2026 in Review

Squadron Capital Management opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 150,000 shares worth $3.74M. The stake represents 0.94% of the portfolio and ranks #31 among its holdings.

257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Squadron Capital Management held 150,000 shares of Tango Therapeutics worth $3.74M as of Q3 2026.
  • Tango Therapeutics was a new Squadron Capital Management position in Q3 2026.
  • Tango Therapeutics made up 0.94% of Squadron Capital Management's portfolio in Q3 2026, its #31 holding.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Squadron Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.